Background & aims Sarcopenia is a risk factor for adverse outcomes in older adults, but this
has yet to be confirmed in chronic kidney disease (CKD). We conducted a systematic review …

Sarcopenia is a risk factor for adverse clinical outcomes in chronic kidney disease (CKD)
patients, including mortality. Diagnosis depends on adopted consensus definition and cutoff …

Sarcopenia in end-stage kidney disease patients requiring dialysis is a frequent
complication but remains an under-recognized problem. This meta-analysis was conducted …

Sarcopenia, a condition characterized by loss of skeletal muscle mass and function, has
important clinical ramifications. We aimed to map the existing literature about prevalence …

There is no consensus on the prevalence of sarcopenia or its impact on mortality in end‐
stage renal disease patients undergoing dialysis. This review aimed to summarize the …

The term sarcopenia was first introduced in 1988 by Irwin Rosenberg to define a condition of
muscle loss that occurs in the elderly. Since then, a broader definition comprising not only …

Most epidemiologic studies assessing the relationship between chronic kidney disease
(CKD) and sarcopenia have been performed in dialysis patients. This study aimed to …

Introduction Sarcopenia is a chronic condition that is associated with aging and
characterized by a reduction of muscle mass, strength, and function. Sarcopenia is prevalent …

Background Sarcopenia, a degenerative and generalized skeletal muscle disorder involving
the loss of muscle function and mass, is an under‐recognized problem in clinical practice …

Background In chronic kidney disease (CKD), multiple metabolic and nutritional
abnormalities contribute to the impairment of skeletal muscle mass and function thus …